CD163 and Miyoshi myopathy: However, contrary to Salmi et al [12], who evaluated mainly the expression of TAM receptors in CD68+ and CD163+ macrophages in benign and malignant melanocytic lesions, our study focused on the correlation between the expression of TAM receptors and the histological main types of MM, with the relative clinicopathological correlations.